Literature DB >> 8446772

PCR analysis of HIV1 infection of macrophages: virus entry is CD4-dependent.

M Collin1, G Herbein, L Montaner, S Gordon.   

Abstract

Amplification of early reverse transcripts by the polymerase chain reaction has been used to measure HIV1 entry into H9 cells and primary macrophages. With a single-step method of DNA preparation, we performed time course experiments to follow the appearance of long terminal repeat DNA. In both cell types, the formation of DNA was completely inhibited by anti-CD4 antibody, confirming the requirement of CD4 for virus binding and entry, and demonstrating that there were no CD4-independent routes of infection. In agreement with previous infectivity studies, sCD4 inhibited the entry of IIIB into H9, but only partially blocked Ba-L into macrophage when used at a comparable dose.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446772     DOI: 10.1016/s0923-2516(06)80006-3

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  12 in total

1.  Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.

Authors:  G Herbein; L J Montaner; S Gordon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Sequences in the 5' and 3' R elements of human immunodeficiency virus type 1 critical for efficient reverse transcription.

Authors:  Y Ohi; J L Clever
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha.

Authors:  V Karsten; S Gordon; A Kirn; G Herbein
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes.

Authors:  G Herbein; C Van Lint; J L Lovett; E Verdin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 6.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Genetic dissociation of the encapsidation and reverse transcription functions in the 5' R region of human immunodeficiency virus type 1.

Authors:  J L Clever; D A Eckstein; T G Parslow
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers.

Authors:  Makobetsa Khati; Michael Schüman; Jamal Ibrahim; Quentin Sattentau; Siamon Gordon; William James
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level.

Authors:  H Schmidtmayerova; M Alfano; G Nuovo; M Bukrinsky
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

10.  Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.

Authors:  L J Montaner; A G Doyle; M Collin; G Herbein; P Illei; W James; A Minty; D Caput; P Ferrara; S Gordon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.